US$ 25.42
kokumi glutathione Enzymatic synthesis and sensory evaluation of the novel compound N-butyryl phenylalanine Kokumi Substance as an Enhancer
Description
systemic adverse events are rare in preliminary reports

PBS/S was used as blocking buffer while PBS/S/T was used as dilution and washing buffers

Ismail, H

Secondary objectives include evaluation of NAC to reduce self-reported symptoms of (1) PTSD, (2) depression and anxiety, (3) substance use, (4) craving and (5) somatic symptoms

C., Acosta, D

Enasidenib Plus Azacitidine Versus Azacitidine Alone in Patients With Newly Diagnosed, Mutant-IDH2 Acute Myeloid Leukaemia (AG221-AML-005): A Single-Arm, Phase 1b and Randomised, Phase 2 Trial
